Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs

Biomolecules. 2020 Dec 11;10(12):1661. doi: 10.3390/biom10121661.

Abstract

Multivalent antibody constructs have a broad range of clinical and biotechnological applications. Nanobodies are especially useful as components for multivalent constructs as they allow increased valency while maintaining a small molecule size. We here describe a novel, rapid method for the generation of bi- and multivalent nanobody constructs with oriented assembly by Cu-free strain promoted azide-alkyne click chemistry (SPAAC). We used sortase A for ligation of click chemistry functional groups site-specifically to the C-terminus of nanobodies before creating C-to-C-terminal nanobody fusions and 4-arm polyethylene glycol (PEG) tetrameric nanobody constructs. We demonstrated the viability of this approach by generating constructs with the SARS-CoV-2 neutralizing nanobody Ty1. We compared the ability of the different constructs to neutralize SARS-CoV-2 pseudotyped virus and infectious virus in neutralization assays. The generated dimers neutralized the virus similarly to a nanobody-Fc fusion variant, while a 4-arm PEG based tetrameric Ty1 construct dramatically enhanced neutralization of SARS-CoV-2, with an IC50 in the low picomolar range.

Keywords: PEG linker; SARS-CoV-2; Single-domain antibody fragment; click chemistry; multivalent; nanobody; neutralization; sortase A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / chemistry
  • Antibodies, Neutralizing / immunology*
  • Antibodies, Neutralizing / pharmacology
  • COVID-19 / immunology*
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • Click Chemistry
  • Humans
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / immunology*
  • SARS-CoV-2 / pathogenicity
  • Single-Domain Antibodies / chemistry
  • Single-Domain Antibodies / immunology*
  • Single-Domain Antibodies / pharmacology

Substances

  • Antibodies, Neutralizing
  • Single-Domain Antibodies